The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
4D MOLECULAR THERAPEUTICS INC COM 35104E100 5,024 229,000 SH   SOLE   229,000 0 0
AVALO THERAPEUTICS INC COM 05338F108 2,481 1,459,400 SH   SOLE   1,459,400 0 0
AVEO BIOSCIENCES INC COM NEW 053588307 1,235 263,400 SH   SOLE   263,400 0 0
BIOLINERX LTD SPONSORED ADS 09071M205 34 16,667 SH   SOLE   16,667 0 0
BRIDGEBIO PHARMA INC COM 10806X102 5,473 328,100 SH   SOLE   328,100 0 0
CELLDEX THERAPEUTICS INC COM NEW 15117B202 32,612 844,000 SH   SOLE   844,000 0 0
CHIMERIX INC COM 16934W106 35,879 5,580,000 SH   SOLE   5,580,000 0 0
CODEXIS INC COM 192005106 42,058 1,345,000 SH   SOLE   1,345,000 0 0
CRINETICS PHARMACEUTICALS INC COM 22663K107 20,580 724,400 SH   SOLE   724,400 0 0
CYTOKINETICS INC COM NEW 23282W605 26,436 580,000 SH   SOLE   580,000 0 0
ETON PHARMACEUTICALS INC COM 29772L108 10,232 2,385,000 SH   SOLE   2,385,000 0 0
FORTRESS BIOTECH INC COM 34960Q109 9,375 3,750,000 SH   SOLE   3,750,000 0 0
GINKGO BIOWORKS HOLDINGS INC CLASS A SHARES 37611X100 7,726 929,780 SH   SOLE   929,780 0 0
HARROW HEALTH INC COM 415858109 28,382 3,285,000 SH   SOLE   3,285,000 0 0
HYPERFINE INC COM CL A 44916K106 5,523 763,075 SH   SOLE   763,075 0 0
KEROS THERAPEUTICS INC COM 492327101 15,549 265,750 SH   SOLE   265,750 0 0
KINIKSA PHARMACEUTICALS LTD COM CL A G5269C101 12,064 1,025,000 SH   SOLE   1,025,000 0 0
LARIMAR THERAPEUTICS INC COM 517125100 9,534 883,602 SH   SOLE   883,602 0 0
LIQUIDIA CORPORATION COM NEW 53635D202 82 16,800 SH   SOLE   16,800 0 0
MACROGENICS INC COM 556099109 7,415 462,000 SH   SOLE   462,000 0 0
MEI PHARMA INC COM NEW 55279B202 3,511 1,315,000 SH   SOLE   1,315,000 0 0
MERUS N.V. COM N5749R100 10,106 317,800 SH   SOLE   317,800 0 0
NEOLEUKIN THERAPEUTICS INC COM 64049K104 5,048 1,047,300 SH   SOLE   1,047,300 0 0
NUCANA PLC SPONSORED ADR 67022C106 2,830 1,189,000 SH   SOLE   1,189,000 0 0
OCULAR THERAPEUTIX INC COM 67576A100 41,644 5,974,800 SH   SOLE   5,974,800 0 0
PROQR THERAPEUTICS NV SHS EURO N71542109 11,498 1,435,510 SH   SOLE   1,435,510 0 0
PROTAGONIST THERAPEUTICS INC COM 74366E102 11,696 342,000 SH   SOLE   342,000 0 0
PROTARA THERAPEUTICS INC COM STK 74365U107 17,996 2,650,000 SH   SOLE   2,650,000 0 0
REATA PHARMACEUTICALS INC CLASS A 75615P103 8,702 330,000 SH   SOLE   330,000 0 0
SEMLER SCIENTIFIC INC COM 81684M104 15,764 172,000 SH   SOLE   172,000 0 0
SIERRA ONCOLOGY INC COM NEW 82640U404 3,604 165,778 SH   SOLE   165,778 0 0
STEREOTAXIS INC COM NEW 85916J409 15,664 2,526,500 SH   SOLE   2,526,500 0 0
SUTRO BIOPHARMA INC COM 869367102 10,118 680,000 SH   SOLE   680,000 0 0
SYNLOGIC INC COM 87166L100 2,057 850,000 SH   SOLE   850,000 0 0
TELA BIO INC COM 872381108 5,758 449,867 SH   SOLE   449,867 0 0
TRACON PHARMACEUTICALS INC COM NEW 89237H209 8,462 3,055,000 SH   SOLE   3,055,000 0 0
VAXCYTE INC COM 92243G108 7,513 315,800 SH   SOLE   315,800 0 0
VERASTEM INC COM 92337C104 4,766 2,325,000 SH   SOLE   2,325,000 0 0
XOMA CORP DEL COM NEW 98419J206 7,055 338,350 SH   SOLE   338,350 0 0